BRIEF-Avexis To Initiate Screening For Remaining Patients In Pivotal Trial Of AVXS-101
Reuters Staff
1 Min Read
Jan 30 (Reuters) - Avexis Inc:
* AVEXIS TO INITIATE SCREENING FOR REMAINING PATIENTS IN PIVOTAL TRIAL OF AVXS-101 FOR SMA TYPE 1 FOLLOWING REVIEW OF PRELIMINARY DATA FROM FIRST THREE PATIENTS Source text for Eikon: Further company coverage: